Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. Hui

P1.01-81 Phase 3 Study of Pemetrexed-Platinum With or Without Pembrolizumab for TKI-Resistant/EGFR-Mutated Advanced NSCLC: KEYNOTE-789

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.04-11 Exploring the Germ-Line Contribution to Exceptional Response to PD-1/PD-L1 Inhibition in Patients With NSCLC by Whole Genome Sequencing

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.16-05 Effect of Induction Chemotherapy in the PACIFIC Study

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-35 Outcomes in Advanced Non-Small Cell Lung Cancer After Discontinuation of PD-1 Checkpoint Inhibitor Due to Toxicity. A Retrospective Study

Journal of Thoracic Oncology

Respiratory Medicine

English

MA10.08 Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

MA05.02 PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated With Durvalumab vs. Placebo After CRT

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.16-04 Outcomes of Patients <70 or ≥70 Years of Age in PACIFIC

Journal of Thoracic Oncology

Respiratory Medicine

English

PL02.01 Overall Survival With Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results From PACIFIC

Journal of Thoracic Oncology

Respiratory Medicine

English

PD.1.01 Health-Related Quality of Life With Pembrolizumab or Placebo + Pemetrexed + Platinum in Non-Squamous NSCLC: KEYNOTE-189

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.16-06 Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%

Journal of Thoracic Oncology

Respiratory Medicine

English